Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

504
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
504
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

8.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

Science translational medicine·2026
Same author

Follow the data: tracking data quality and completeness in oncology real-world data.

JAMIA open·2026
Same author

An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation study.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluation of electronic health record to HL7® FHIR® mappings in pediatric research studies.

International journal of medical informatics·2026
Same author

Extending the Observational Medical Outcomes Partnership (OMOP) Common Data Model for Critical Care Medicine: A Framework for Standardizing Complex ICU Data Using the Society of Critical Care Medicine's Critical Care Data Dictionary (C2D2).

Critical care medicine·2025
Same author

Leveraging the Rural-Urban Commuting Area Tool to Address Geographic Disparities in Cancer Care: A Dual-Application Framework for Institutional and National Initiatives.

JCO clinical cancer informatics·2025

相关实验视频

Updated: Jan 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.0K

动态对比增强MRI用于评估乳腺癌化疗反应使用条件生成对抗网络.

Chad A Arledge1, Alan H Zhao2, Umit Topaloglu3,4

  • 1Department of Biomedical Engineering, Wake Forest School of Medicine, 525 Vine St, Ste 150, Winston-Salem, NC 27101.

Radiology. Imaging cancer
|December 5, 2025
PubMed
概括

一个新的条件生成对抗网络 (cGAN) 将动态对比增强的MRI数据转换为血管透性图,显著减少计算时间. 这种方法对预测乳腺癌对新辅助化疗的反应有希望.

关键词:
乳腺癌 乳腺癌 乳腺癌动态对比增强MRI的动态对比增强图像对图像条件生成对抗网络新辅助化学疗法 新辅助化学疗法血管透性 血管透性

更多相关视频

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

相关实验视频

Last Updated: Jan 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.0K
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

科学领域:

  • 放射学和医学成像学 医学成像学
  • 人工智能在医学中的应用
  • 在瘤学瘤学.

背景情况:

  • 动态对比增强磁共振成像 (DCE-MRI) 对于评估血管透性至关重要.
  • 药物动力学建模,就像扩展的托夫特模型 (ETM) 一样,提供了定量透性图 (Ktrans),但在计算上是密集的.
  • 准确高效的基因转移映射对于癌症诊断和治疗反应评估至关重要.

研究的目的:

  • 开发和评估一个图像对图像条件生成对抗网络 (cGAN),用于将DCE-MRI数据转化为血管药物动力学透性图.
  • 将cGAN衍生Ktrans图的计算效率和准确性与已建立的ETM进行比较.
  • 评估cGAN方法在接受新辅助化疗的乳腺癌患者预测治疗反应方面的潜力.

主要方法:

  • 乳腺癌DCE-MRI扫描的回顾性队列被用于训练和验证cGAN.
  • 扩展的Tofts模型 (ETM) 用于生成参考标准Ktrans地图.
  • 使用线性回归,逻辑回归和对 t 测试来评估一致性,空间相似性和预测能力.

主要成果:

  • 与ETM相比,cGAN实现了超过1000倍的计算时间缩短.
  • cGAN Ktrans地图显示出优异的空间一致性和与ETM地图的高度结构相似性 (R2 ≥ 0.98).
  • 在新辅助化疗后,cGAN Ktrans的百分比变化有效地区分了病理完整反应 (60%的减少) 和没有 (17%的减少) 的患者.

结论:

  • 开发的DCE-to-pharmacokinetic cGAN为DCE-MRI中药物动力学分析提供了一种标准化和计算效率高的方法.
  • 这种人工智能驱动的方法显示了早期预测乳腺癌对新辅助化疗反应的巨大潜力.
  • 在临床瘤学中,cGAN促进了更快,更容易获得的定量成像生物标记分析.